ExpertiseUpdated on 25 June 2025
ATMP Developers from Bench to Bedside
Marketing and Strategy Department Lead at Creatio- Universitat de Barcelona
Barcelona, Spain
About
Creatio offers tailored, high-quality support to public and private stakeholders to accelerate the development of ATMPs — from lab to patient.
Our solutions cover the full value chain, from early-stage research to clinical-grade manufacturing, in full compliance with GMP, GLP, and ISO 9001:2015 standards.
Core Activities:
-
GMP-compliant production and validation of gene, cell, and tissue-engineered (3D bioprinted) ATMPs
-
Regulatory and clinical translation support
-
Preclinical studies (efficacy, PK/PD, tolerance, clinical pathology)
-
GLP-compliant toxicology studies (in vitro and in vivo toxicity)
-
Regulatory and preclinical support
-
Scientific and technical training
Whether you're an academic lab, biotech startup, SME, or pharmaceutical company, Creatio is your strategic partner to develop and deliver next-generation therapies with real clinical and societal impact.
Similar opportunities
Service
Clinical Trial Supply & Logistics Services
- Development
- Manufacturing
- Pharmaceutical industry
Marc Brehme
Founder & Managing Director at M-B-V-C
Vienna, Austria
Service
Custom Lipid Nanoparticle Delivery Systems for Pharma & Biotech
- Development
- Health innovation
- Pharmaceutical industry
Guillermo Calvo Navarrete
Scientific Partnerships Manager at DIVERSA TECHNOLOGIES SL
Santiago de Compostela, Spain
Product
ThymoTropin™ – Natural Myostatin-Regulating Ingredient for Muscle Health
- Health innovation
- Distribution Partner
- Pharmaceutical industry
Bassam Damaj
President at Veos Pharmaceuticals, SL
Madrid, Madrid, Spain